| Code | CSB-RA197122A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
| IF | 1:50-1:200 |
| FC | 1:50-1:200 |
PRKAR2A serves as the type II-alpha regulatory subunit of cAMP-dependent protein kinase, playing a central role in the cAMP signaling cascade that governs diverse cellular processes including metabolism, gene expression, and cell proliferation. As a key modulator of protein kinase A activity, PRKAR2A has drawn significant research interest for its involvement in cancer biology and metabolic regulation, where dysregulated cAMP signaling can drive pathological outcomes.
This recombinant monoclonal antibody, clone 15G8, offers the reproducibility and consistency that demanding research applications require. Generated against a synthetic peptide derived from human PRKAR2A and produced using recombinant technology, this antibody provides sequence-defined specificity with minimal lot-to-lot variation, ensuring your experimental results remain comparable across studies and over time.
Validation across multiple detection platforms demonstrates this antibody's versatility in your workflow. Immunohistochemistry studies confirm reliable staining in paraffin-embedded human tissues, with clear detection observed in both normal kidney tissue and rectal cancer specimens at 1:50 dilution using citrate buffer antigen retrieval. For cellular localization studies, immunofluorescence analysis in HeLa cells reveals distinct staining patterns when counterstained with DAPI. Flow cytometry validation using MCF-7 breast cancer cells shows a clear positive shift compared to isotype control, confirming utility for quantitative single-cell analysis of PRKAR2A expression.
Supplied in a glycerol-containing buffer optimized for long-term stability, this antibody supports researchers investigating cAMP-dependent signaling networks, metabolic regulation, and oncogenic pathways where protein kinase A activity influences disease progression and therapeutic response.
There are currently no reviews for this product.